Table 1

The clinico-pathological characteristics of patients with primary operable invasive ductal breast cancer (n = 384)
Clinico-pathological characteristics Patients (n)
Age (≤50/>50 years) 107 (28%)/277 (72%)
Size (≤20/21-50/≥50 mm) 218 (57%)/154 (40%)/11 (3%)
Grade (I/II/III) 70 (18%)/157 (41%)/157 (41%)
Involved lymph node (0/1-3/>3) 205 (53%)/108 (28%)/66 (17%)
Oestrogen -receptor status (ER-/ER+) 124 (32%)/237 (62%)
Progesterone -receptor status (PR-/PR+) 193 (50%)/170 (44%)
HER-2 status (HER-2 -/HER-2+) 299 (78%)/65 (17%)
Ki-67 status (Low Ki-67/High Ki-67) 272 (71%)/92 (24%)
LVI (Absent/Present) 234 (61%)/150 (39%)
MVD (CD34+) (tertiles 1, 2, 3) 137 (36%)/126 (33%)/106 (28%)
Loco-regional treatment (Lumpectomy + radiotherapy/mastectomy + radiotherapy) 142 (37%)/242 (63%)
Systemic treatment (ER-based treatment) (hormonal/hormonal + chemotherapy/chemotherapy/none) 192 (50%)/86 (22%)/80 (21%)/22 (6%)

Mohammed et al.

Mohammed et al. BMC Clinical Pathology 2013 13:31   doi:10.1186/1472-6890-13-31

Open Data